122 related articles for article (PubMed ID: 7694662)
1. Expression of adhesion molecules on acute leukemic blast cells and sensitivity to normal LAK activity.
Raspadori D; Lauria F; Ventura MA; Rondelli D; Tura S
Ann Hematol; 1993 Nov; 67(5):213-6. PubMed ID: 7694662
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of acute myelogenous leukemia blasts to lysis by lymphokine-activated killer (LAK) cells and its clinical relevance.
Archimbaud E; Thomas X; Campos L; Fiere D; Doré JF
Leuk Res; 1992; 16(6-7):673-80. PubMed ID: 1378919
[TBL] [Abstract][Full Text] [Related]
3. Possible mechanism of selective killing of myeloid leukemic blast cells by lymphokine-activated killer cells.
Oblakowski P; Bello-Fernandez C; Reittie JE; Heslop HE; Galatowicz G; Veys P; Wilkes S; Prentice HG; Hazlehurst G; Hoffbrand AV
Blood; 1991 May; 77(9):1996-2001. PubMed ID: 1708296
[TBL] [Abstract][Full Text] [Related]
4. Increased susceptibility to lymphokine activated killer (LAK) lysis of relapsing vs. newly diagnosed acute leukemic cells without changes in drug resistance or in the expression of adhesion molecules.
Arienti F; Gambacorti-Passerini C; Borin L; Rivoltini L; Orazi A; Pogliani EM; Corneo G; Parmiani G
Ann Oncol; 1992 Feb; 3(2):155-62. PubMed ID: 1606087
[TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibility of acute leukemia cells to the cytotoxic activity of allogeneic and autologous lymphokine activated killer (LAK) effectors: correlation with the rate and duration of complete remission and with survival.
Lauria F; Raspadori D; Rondelli D; Ventura MA; Foà R
Leukemia; 1994 May; 8(5):724-8. PubMed ID: 8182932
[TBL] [Abstract][Full Text] [Related]
6. Conjugate formation by leukemic blasts from acute myeloid leukemia with cytotoxic lymphocytes.
Palucka AK; Porwit A; Reizenstein P
Leuk Lymphoma; 1993 Nov; 11(5-6):427-33. PubMed ID: 7907248
[TBL] [Abstract][Full Text] [Related]
7. Expression of surface adhesion molecules CD54 (ICAM-1) and CD58 (LFA-3) in adult acute leukemia: relationship with initial characteristics and prognosis.
Archimbaud E; Thomas X; Campos L; Magaud JP; Doré JF; Fiere D
Leukemia; 1992 Apr; 6(4):265-71. PubMed ID: 1375302
[TBL] [Abstract][Full Text] [Related]
8. Effect of human interleukin 3 on the susceptibility of fresh leukemia cells to interleukin-2-induced lymphokine activated killing activity.
Cesano A; Lista P; Bellone G; Geuna M; Brizzi MF; Rossi PR; Pegoraro L; Oberholtzer E; Matera L
Leukemia; 1992 Jun; 6(6):567-73. PubMed ID: 1376379
[TBL] [Abstract][Full Text] [Related]
9. Defective lymphokine-activated killer cell generation and activity in acute leukemia patients with active disease.
Foa R; Fierro MT; Cesano A; Guarini A; Bonferroni M; Raspadori D; Miniero R; Lauria F; Gavosto F
Blood; 1991 Aug; 78(4):1041-6. PubMed ID: 1868239
[TBL] [Abstract][Full Text] [Related]
10. Resistance of leukemic blasts to lymphokine activated killer (LAK)-mediated cytotoxicity is not related to their adhesion properties.
Palucka AK; Porwit A; Reizenstein P
Eur J Haematol; 1991 Aug; 47(2):123-7. PubMed ID: 1716215
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of adult acute lymphoblastic leukemia blasts to lysis by lymphokine-activated killer cells.
Archimbaud E; Thomas X; Campos L; Magaud JP; Fiere D; Doré JF
Leukemia; 1991 Nov; 5(11):967-71. PubMed ID: 1961038
[TBL] [Abstract][Full Text] [Related]
12. Potential role for non-HLA-restricted cytotoxic cells in the immune surveillance of acute leukemia.
Archimbaud E; Campos L; Vila L; Thomas X
Immunol Lett; 1993 Dec; 39(1):13-5. PubMed ID: 7511562
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of cell adhesion molecules CD54/CD11a and CD58/CD2 by human melanoma cells and functional role in their interaction with cytotoxic cells.
Altomonte M; Gloghini A; Bertola G; Gasparollo A; Carbone A; Ferrone S; Maio M
Cancer Res; 1993 Jul; 53(14):3343-8. PubMed ID: 7686816
[TBL] [Abstract][Full Text] [Related]
14. Induction of death (CD95/FAS), activation and adhesion (CD54) molecules on blast cells of acute myelogenous leukemias by TNF-alpha and IFN-gamma.
Munker R; Andreeff M
Cytokines Mol Ther; 1996 Sep; 2(3):147-59. PubMed ID: 9384699
[TBL] [Abstract][Full Text] [Related]
15. CD10/common acute lymphoblastic leukemia-associated antigen and adhesion factor expression is predictive for lymphokine-activated killing sensitivity of adult B-lineage acute lymphoblastic leukemia.
Correale P; Tagliaferri P; Camera A; Caraglia M; Del Vecchio L; De Laurentis M; Pinto A; Rotoli B; Bianco AR
Year Immunol; 1993; 7():90-5. PubMed ID: 7690510
[No Abstract] [Full Text] [Related]
16. Adhesion molecules on CD34+ hematopoietic cells in normal human bone marrow and leukemia.
Reuss-Borst MA; Bühring HJ; Klein G; Müller CA
Ann Hematol; 1992 Oct; 65(4):169-74. PubMed ID: 1384721
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of human leukemia to allogeneic and autologous lymphokine-activated killer cell activity: analysis of 252 samples.
Teichmann JV; Ludwig WD; Thiel E
Nat Immun; 1992; 11(3):117-32. PubMed ID: 1392400
[TBL] [Abstract][Full Text] [Related]
18. Natural killer cells adhere to bone marrow fibroblasts and inhibit adhesion of acute myeloid leukemia cells.
Bendall LJ; Kortlepel K; Bradstock KF; Gottlieb DJ
Leukemia; 1995 Jun; 9(6):999-1005. PubMed ID: 7596192
[TBL] [Abstract][Full Text] [Related]
19. Lymphokine-activated killer (LAK) cells inhibit the clonogenic growth of human leukemic stem cells.
Lista P; Fierro MT; Liao XS; Bonferroni M; Brizzi MF; Porcu P; Pegoraro L; Foa R
Eur J Haematol; 1989 May; 42(5):425-30. PubMed ID: 2786477
[TBL] [Abstract][Full Text] [Related]
20. Modulation of leukemic cell sensitivity to lymphokine-activated killer cytolysis: role of intercellular adhesion molecule-1.
Triozzi PL; Eicher DM; Smoot J; Rinehart JJ
Exp Hematol; 1992 Oct; 20(9):1072-6. PubMed ID: 1361453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
